FY2025 · period end Dec '25 · from the 10-K filed Feb 25, 2026
Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0.23B | $0.19B | $0.16B | $0.14B | $0.13B |
| Gross Profit | $0.17B | $0.14B | $0.12B | $0.11B | $0.10B |
| Operating Income | negative: -$0.01B | negative: -$0.00B | negative: -$0.02B | negative: -$0.03B | negative: -$0.03B |
| Net Income | negative: -$0.02B | negative: -$0.01B | negative: -$0.02B | negative: -$0.03B | negative: -$0.03B |
| EPS (Diluted) | negative: -$0.34 | negative: -$0.23 | negative: -$0.51 | negative: -$0.69 | negative: -$0.65 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.22B | $0.20B | $0.20B | $0.20B | $0.21B |
| Total Liabilities | $0.09B | $0.10B | $0.10B | $0.09B | $0.10B |
| Stockholders' Equity | $0.13B | $0.10B | $0.10B | $0.10B | $0.11B |
| Cash & Equivalents | $0.04B | $0.03B | $0.03B | $0.02B | $0.03B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.00B | $0.00B | negative: -$0.01B | negative: -$0.02B | negative: -$0.01B |
| Capital Expenditures | $0.00B | $0.00B | $0.01B | $0.02B | $0.03B |
| Free Cash Flow | negative: -$0.00B | $0.00B | negative: -$0.02B | negative: -$0.04B | negative: -$0.04B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 74.3% | 75.8% | 76.6% | 78.5% | 82.0% |
| Operating Margin | negative: -0.0% | negative: -0.0% | negative: -0.1% | negative: -0.2% | negative: -20.0% |
| Net Margin | negative: -0.1% | negative: -0.1% | negative: -0.1% | negative: -0.2% | negative: -21.2% |
| Return on Equity | negative: -13.5% | negative: -10.0% | negative: -22.1% | negative: -27.1% | negative: -24.0% |
| Return on Assets | negative: -7.4% | negative: -5.0% | negative: -11.1% | negative: -14.4% | negative: -13.0% |
| Debt / Equity | 0.38× | 0.46× | 0.49× | 0.45× | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
Who is buying and selling Axogen, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on AXGN yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on AXGN and publish the result to your public profile.
Ask about Axogen, Inc.
Continue in Workspace — cited answers on AXGN, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0000805928-26-000094 | Jun 30, 2026 | Jul 29, 2026 | Jul 30, 2026 00:13 UTC | EDGAR |
| 10-Q | 0000805928-26-000053 | Mar 31, 2026 | Apr 28, 2026 | Apr 29, 2026 00:04 UTC | EDGAR |
| 10-K | 0000805928-26-000031 | Dec 31, 2025 | Feb 24, 2026 | Feb 25, 2026 02:24 UTC | EDGAR |
| 10-Q | 0000805928-25-000130 | Sep 30, 2025 | Oct 29, 2025 | Oct 30, 2025 00:07 UTC | EDGAR |
| 10-Q | 0000805928-25-000107 | Jun 30, 2025 | Aug 5, 2025 | Aug 6, 2025 00:52 UTC | EDGAR |
| 10-Q | 0000805928-25-000064 | Mar 31, 2025 | May 8, 2025 | May 9, 2025 00:38 UTC | EDGAR |
| 10-K | 0000805928-25-000017 | Dec 31, 2024 | Feb 26, 2025 | Feb 27, 2025 02:09 UTC | EDGAR |
| 10-Q | 0000805928-24-000137 | Sep 30, 2024 | Nov 7, 2024 | Nov 8, 2024 02:12 UTC | EDGAR |
| 10-Q | 0000805928-24-000111 | Jun 30, 2024 | Aug 8, 2024 | Aug 9, 2024 00:10 UTC | EDGAR |
| 10-Q | 0000805928-24-000072 | Mar 31, 2024 | May 2, 2024 | May 3, 2024 00:07 UTC | EDGAR |
| 10-K | 0000805928-24-000028 | Dec 31, 2023 | Mar 5, 2024 | Mar 6, 2024 02:27 UTC | EDGAR |
| 10-Q | 0000805928-23-000148 | Sep 30, 2023 | Nov 7, 2023 | Nov 8, 2023 02:03 UTC | EDGAR |
Direct links to SEC EDGAR. AXGN has additional filings available on the SEC site.
6 numbers Axogen, Inc. later changed — same XBRL tag, both filings linked.
Revenues·Q2 2011
Major restatementwas$2.2M
Revised down in a 10-Q. Any P/S built on the original was 83.1% too low.
Assets·As of Dec 31, 2010
Major restatementwas$10.1M
Revised down in a 10-K.
Gross Profit·FY 2022
Notable restatementwas$114.4M
Revised down in a 10-K.
Gross Profit·Q1 2023
Notable restatementwas$30M
Revised down in a 10-Q.
Gross Profit·FY 2023
Notable restatementwas$127.9M
Revised down in a 10-K.
Gross Profit·Q3 2023
Notable restatementwas$33.2M
Revised down in a 10-Q.
AXGN is not the only one.
See every restatement we've found across the market — or get an alert the next time AXGN revises a number.
Restatements are detected by comparing every vintage of a fact across all of Axogen, Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows AXGN's most significant revisions, and a figure absent from it has not been certified as unrevised.
